Retesting of bone donors 2 months after donation guarantees sufficient safety of bone allografts

Acta Orthopaedica Scandinavica

Volumn 69, Issue 6, 1998, Pages 566-569

  Hirn, Martti Y J ^a   Krusius, Tom ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; BONE ALLOGRAFT; BONE INFECTION; BONE TRANSPLANTATION; DONOR; FINLAND; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; SCREENING;

EID: 0032440271     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.3109/17453679808999256     Document Type: Article

References (23)

1. Alter H J, Epstein J S, Swenson S G, VanRaden M J, Ward J W, Kaslow R A, Menitove J E, Klein H G, Sandler S G, Sayers M H, Hewlett I K, Chernoff A I, The HIV-antigen Study Group. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors - an assessment of the efficacy of testing in donor screening. N Engl J Med 1990; 323: 1312-7.
2. Buck B E, Malinin T I, Brown M D. Bone transplantation and human immunodeficiency virus: an estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop 1989; 240: 129-36.
3. Busch M P, Taylor P E, Lenes B A, Kleinman S H, Stuart M, Stevens C E, Tomasulo PA, Allain J-P, Hollingsworth C G, Mosley J W, Transfusion Safety Study Group. Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. N Engl J Med 1990; 323: 1308-12.
4. Busch M P, Lee L L L, Satten G A, Henrard D R, Farzadegan H, Nelson K E, Read S, Dodd R Y, Petersen L R. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995; 35: 91-7.
5. Canadian Medical Association. Anonymous. Consensus statement regarding the HIV "window period". Can Commun Dis Rep 1995; 21 (24): 213-5.
6. Couroucé A-M, Pillonel J. Transfusion-transmitted viral infections. N Engl J Med 1996; 335: 1609-10.
7. Donegan E, Lee H, Operskalski E A, Shaw G M, Kleinman S H, Busch M P, Stevens C E, Schiff E R, Nowicki M J, Hollingsworth C G, Mosley J W. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II, compared with human immunodeficiency virus type 1. Transfusion 1994; 34: 478-83.
8. EATB (European Association of Tissue Banks) and EAMST (European Association of Musculo Skeletal Transplantation) Common Standards for Musculo Skeletal Tissue Banking. Vienna 1997.
9. Horsburgh C R Jr, Ou C Y, Jason J, Holmburg S D, Longini I M Jr, Schable C, Mayer K H, Lifson A R, Schochetman G, Ward J W, Rutherford G W, Evatt B L, Seage G R III, Jaffe H W. Duration of human immunodeficiency virus infection before detection of antibody. Lancet 1989; II (8664): 637-40.
10. Kantanen M L, Koskela P, Leinikki P. Unlinked anonymous HIV screening of pregnant women in a low-prevalence population. Scand J Infect Dis 1996; 28: 3-7.
11. Lefrère J J, Sellami F, Larderie P, Lemaillot C, Roudot-Thoraval F, Claquin J. Six years' experience testing organ donors for viral markers in France. Transfusion 1997; 37: 565-6.
12. Lindholm A. Epidemiology of viral infections in the Swedish blood-donor population. Blood Coagul Fibrinolysis 1994; 5: 13-7.
13. Manns A, Wilks R J, Murphy E L, Haynes G, Figueroa J P, Barnett M, Hanchard B, Blattner W A. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992; 51: 886-91.
14. Munting E, Wilmart J F, Wijne A, Hennebert P, Delloye C. Effect of sterilization on osteoinduction. Acta Orthop Scand 1988; 59: 34-8.
15. Norman-Taylor F H, Santori N, Villar R N. The trouble with bone allograft. We need a safe, abundant alternative. Br Med J 1997; 315: 498.
16. Patijn G A, Strengers P F W, Harvey M, Persijn G. Prevention of transmission of HIV by organ and tissue transplantation. Transpl Int 1993; 6: 165-72.
17. Pereira B J, Milford E L, Kirkman R L, Levey A S, Tomford W W, Leibowitz H, Rhodes M, Quan S, Wilber J C. Low risk of liver disease after tissue transplantation from donors with HCV. Lancet 1993; 341 (8849): 903-4.
18. Pillonel J, Couroucé A-M, Elghouzzi M H, Piquet Y, Lemaire J M. Seroconversions to HTLV in blood donors. Vox Sang 1996; 70: 47.
19. Rabkin C S, Corbin D O C, Felton S, Barker H. Davison D, Dearden C, Blattner W A, Evans A S. Human T-cell lymphotropic virus type 1 infection in Barbados: results of a 20-year follow-up study. J Acquir Immune Defic Syndr 1996; 12: 519-22.
20. Sanzén L, Carlsson Å. Transmission of human T-cell lymphotropic virus type 1 by a deep-frozen bone allograft. Acta Orthop Scand 1997; 68: 72-4.
21. Schreiber G B, Busch M P, Kleinman S H, Korelitz J J. The risk of tranfusion-transmitted viral infections. N Engl J Med 1996; 334: 1685-90.
22. Strong D M, Sayers M H, Conrad E U. Screening tissue donors for infectious markers. In: Bone and cartilage allografts: biology and clinical applications (Eds. Friedlaender G E, Goldberg V M). American Academy of Orthopaedic Surgeons. Park Ridge (IL) 1991; 14: 193-209.
23. Tomford W W. Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg (Am) 1995; 77: 1742-54.